Literature DB >> 2457921

Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.

A A Minassian1, V S Kalyanaraman, R C Gallo, M Popovic.   

Abstract

Four mouse monoclonal antibodies were developed after immunization with one human immunodeficiency virus (HIV) type 2 isolate and were tested for reactivity with different HIV-1, HIV-2, and simian immunodeficiency virus (SIV) isolates in an immunofluorescence assay and by immunological blot analysis. One of them, an anti-capsid (p24) antibody, called R1C7, reacted with all HIV-1, HIV-2, and SIV isolates tested, thus identifying an epitope shared by all HIV and SIV. Another anti-capsid antibody, named A4F6, reacted with three HIV-2 isolates (HIV-2NIH-Z, LAV-2Rod, and LK001 ST9), some SIV isolates (STLV-IIIAGM, SIV-251, and SIV-309), but no HIV-1 isolates. Two anti-matrix (p16) antibodies, named R5C4 and R5F6, reacted strongly only with the HIV-2 isolates. The use of these monoclonal antibodies for rapid discrimination and identification of acquired immunodeficiency syndrome-related retroviruses is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457921      PMCID: PMC282094          DOI: 10.1073/pnas.85.18.6939

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

2.  Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

Authors:  J Schüpbach; O Haller; M Vogt; R Lüthy; H Joller; O Oelz; M Popovic; M G Sarngadharan; R C Gallo
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

3.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia.

Authors:  M Robert-Guroff; Y Nakao; K Notake; Y Ito; A Sliski; R C Gallo
Journal:  Science       Date:  1982-02-19       Impact factor: 47.728

5.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

6.  Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.

Authors:  M D Daniel; N L Letvin; N W King; M Kannagi; P K Sehgal; R D Hunt; P J Kanki; M Essex; R C Desrosiers
Journal:  Science       Date:  1985-06-07       Impact factor: 47.728

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys.

Authors:  P J Kanki; J Alroy; M Essex
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

9.  Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.

Authors:  F di Marzo Veronese; M G Sarngadharan; R Rahman; P D Markham; M Popovic; A J Bodner; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  17 in total

1.  A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease.

Authors:  M Watanabe; D J Ringler; P N Fultz; J J MacKey; J E Boyson; C G Levine; N L Letvin
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1.

Authors:  V Robert; M Resnicoff; J C Chermann; C Devaux
Journal:  Mol Cell Biochem       Date:  1991-04-10       Impact factor: 3.396

3.  Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.

Authors:  M Niedrig; J Hinkula; H P Harthus; M Bröker; L Hopp; G Pauli; B Wahren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy.

Authors:  D J Ringler; M S Wyand; D G Walsh; J J MacKey; L V Chalifoux; M Popovic; A A Minassian; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.

Authors:  X Wu; H Liu; H Xiao; J A Conway; J C Kappes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Cytokine influence on simian immunodeficiency virus replication within primary macrophages. TNF-alpha, but not GMCSF, enhances viral replication on a per-cell basis.

Authors:  D G Walsh; C J Horvath; A Hansen-Moosa; J J MacKey; P K Sehgal; M D Daniel; R C Desrosiers; D J Ringler
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.

Authors:  M Watanabe; D J Ringler; M Nakamura; P A DeLong; N L Letvin
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Generation, characterization and cross-reactivities of monoclonal antibodies against the p24 core protein and the gp130 envelope glycoprotein of HIV-2ben.

Authors:  A C Faisst; A Otteken; S Nick; G Hunsmann
Journal:  Med Microbiol Immunol       Date:  1993-07       Impact factor: 3.402

9.  Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.

Authors:  X Wu; J A Conway; J Kim; J C Kappes
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Macrophage-tropic variants of SIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS.

Authors:  R C Desrosiers; A Hansen-Moosa; K Mori; D P Bouvier; N W King; M D Daniel; D J Ringler
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.